Proposed approval of the new active constituent tiafenacil

This consultation closed on 14 January 2020.
Consultation period: 
17 December 2019 to 14 January 2020

We invite comments from 17 December 2019 to 14 January 2020 on whether the application for approval of tiafenacil should be granted.

The APVMA is able to consider comments relating to the legislative ground for approval, including:

  • public health
  • chemistry and manufacture.

For more information, see page 28 of Gazette No. 25, 17 December 2019.

Please send your written submission by email or post to:

Director of Chemistry and Manufacture
Risk Assessment Capability Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Phone: +61 2 6770 2300
Email: enquiries@apvma.gov.au

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.